The role of signalling in cellular cholesterol homeostasis

IUBMB Life

Volumn 65, Issue 8, 2013, Pages 675-684

  Luu, Winnie ^a   Sharpe, Laura J ^a   Gelissen, Ingrid C ^b   Brown, Andrew J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

ABCA1; cholesterol; efflux; kinase; phosphorylation; signalling

Indexed keywords

ABC TRANSPORTER A1; CASEIN KINASE II; CHOLESTEROL; CYCLIC AMP; JANUS KINASE 2; LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE; PHOSPHOTRANSFERASE; PROTEIN KINASE C; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LXR; TRANSCRIPTION FACTOR SREBP 2; UNCLASSIFIED DRUG;

CELL SURVIVAL; CELLULAR CHOLESTEROL HOMEOSTASIS; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; HOMEOSTASIS; HUMAN; MEDICAL RESEARCH; PHOSPHORYLATION; REVIEW; SYNTHESIS;

EID: 84890699334     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1182     Document Type: Review

References (62)

1. Moorhead, G. B., Trinkle-Mulcahy, L., and, Ulke-Lemee, A., (2007) Emerging roles of nuclear protein phosphatases. Nat. Rev. Mol. Cell Biol. 8, 234-244.
2. Brown, A. J., (2007) Cholesterol, statins and cancer. Clin. Exp. Pharmacol. Physiol. 34, 135-141. (Pubitemid 46148252)
3. Krycer, J. R., Sharpe, L. J., Luu, W., and, Brown, A. J., (2010) The Akt-SREBP nexus: cell signaling meets lipid metabolism. Trends Endocrinol. Metab. 21, 268-276.
4. Solomon, K. R., and, Freeman, M. R., (2011) The complex interplay between cholesterol and prostate malignancy. Urol. Clin. N Am. 38, 243-259.
5. Krycer, J. R., and, Brown, A. J., (2013) Cholesterol accumulation in prostate cancer: a classic observation from a modern perspective. Biochim. Biophys. Acta 1835, 219-229.
6. Du, X., Kristiana, I., Wong, J., and, Brown, A. J., (2006) Involvement of Akt in ER-to-Golgi transport of SCAP/SREBP: a link between a key cell proliferative pathway and membrane synthesis. Mol. Biol. Cell 17, 2735-2745. (Pubitemid 43825509)
7. Luu, W., Sharpe, L. J., Stevenson, J., and, Brown, A. J., (2012) Akt acutely activates the cholesterogenic transcription factor SREBP-2. Biochim. Biophys. Acta 1823, 458-464.
8. Sharpe, L. J., and, Brown, A. J., (2008) Rapamycin down-regulates LDL-receptor expression independently of SREBP-2. Biochem. Biophys. Res. Commun. 373, 670-674.
9. Porstmann, T., Santos, C. R., Griffiths, B., Cully, M., Wu, M., et al. (2008) SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 8, 224-236.
10. Sundqvist, A., Bengoechea-Alonso, M. T., Ye, X., Lukiyanchuk, V., Jin, J., et al. (2005) Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7). Cell Metab. 1, 379-391. (Pubitemid 43960622)
11. Bengoechea-Alonso, M. T., and, Ericsson, J., (2009) A phosphorylation cascade controls the degradation of active SREBP1. J. Biol. Chem. 284, 5885-5895.
12. Kotzka, J., Lehr, S., Roth, G., Avci, H., Knebel, B., et al. (2004) Insulin-activated Erk-mitogen-activated protein kinases phosphorylate sterol regulatory element-binding Protein-2 at serine residues 432 and 455 in vivo. J. Biol. Chem. 279, 22404-22411. (Pubitemid 38679438)
13. Arito, M., Horiba, T., Hachimura, S., Inoue, J., and, Sato, R., (2008) Growth factor-induced phosphorylation of sterol regulatory element-binding proteins inhibits sumoylation, thereby stimulating the expression of their target genes, low density lipoprotein uptake, and lipid synthesis. J. Biol. Chem. 283, 15224-15231.
14. Chen, M., Bradley, M. N., Beaven, S. W., and, Tontonoz, P., (2006) Phosphorylation of the liver X receptors. FEBS Lett. 580, 4835-4841. (Pubitemid 44286840)
15. Torra, I. P., Ismaili, N., Feig, J. E., Xu, C. F., Cavasotto, C., et al. (2008) Phosphorylation of liver X receptor alpha selectively regulates target gene expression in macrophages. Mol. Cell. Biol. 28, 2626-2636. (Pubitemid 351542363)
16. Berrabah, W., Aumercier, P., Lefebvre, P., and, Staels, B., (2011) Control of nuclear receptor activities in metabolism by post-translational modifications. FEBS Lett. 585, 1640-1650.
17. Hornbeck, P. V., Kornhauser, J. M., Tkachev, S., Zhang, B., Skrzypek, E., et al. (2012) PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 40, D261-D270.
18. Beg, Z. H., Allmann, D. W., and, Gibson, D. M., (1973) Modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity with cAMP and wth protein fractions of rat liver cytosol. Biochem. Biophys. Res. Commun. 54, 1362-1369.
19. Oakhill, J. S., Scott, J. W., and, Kemp, B. E., (2012) AMPK functions as an adenylate charge-regulated protein kinase. Trends Endocrinol. Metab. 23, 125-132.
20. Clarke, P. R., and, Hardie, D. G., (1990) Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver. EMBO J. 9, 2439-2446.
21. Burg, J. S., and, Espenshade, P. J,. (2011) Regulation of HMG-CoA reductase in mammals and yeast. Prog. Lipid Res. 50, 403-410.
22. Sato, R., Goldstein, J. L., and, Brown, M. S., (1993) Replacement of serine-871 of hamster 3-hydroxy-3-methylglutaryl-CoA reductase prevents phosphorylation by AMP-activated kinase and blocks inhibition of sterol synthesis induced by ATP depletion. Proc. Natl. Acad. Sci. USA 90, 9261-9265. (Pubitemid 23315763)
23. DeBose-Boyd, R. A., (2008) Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res. 18, 609-621.
24. Srivastava, R. A., Pinkosky, S. L., Filippov, S., Hanselman, J. C., Cramer, C. T., et al. (2012) AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases. J. Lipid Res. 53, 2490-2514.
25. Min, H. K., Kapoor, A., Fuchs, M., Mirshahi, F., Zhou, H., et al. (2012) Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab. 15, 665-674.
26. Kishimoto, A., Brown, M. S., Slaughter, C. A., and, Goldstein, J. L., (1987) Phosphorylation of serine 833 in cytoplasmic domain of low density lipoprotein receptor by a high molecular weight enzyme resembling casein kinase II. J. Biol. Chem. 262, 1344-1351. (Pubitemid 17028456)
27. Cao, A., Wu, M., Li, H., and, Liu, J., (2011) Janus kinase activation by cytokine oncostatin M decreases PCSK9 expression in liver cells. J. Lipid Res. 52, 518-530.
28. Dewpura, T., Raymond, A., Hamelin, J., Seidah, N. G., Mbikay, M., et al. (2008) PCSK9 is phosphorylated by a Golgi casein kinase-like kinase ex vivo and circulates as a phosphoprotein in humans. FEBS J. 275, 3480-3493. (Pubitemid 351813558)
29. Fisher, E. A., Feig, J. E., Hewing, B., Hazen, S. L., and, Smith, J. D., (2012) High-density lipoprotein function, dysfunction, and reverse cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 32, 2813-2820.
30. Liu, Y., and, Tang, C., (2012) Regulation of ABCA1 functions by signaling pathways. Biochim. Biophys. Acta 1821, 522-529.
31. Mulay, V., Wood, P., Rentero, C., Enrich, C., and, Grewal, T., (2012) Signal transduction pathways provide opportunities to enhance HDL and apoAI-dependent reverse cholesterol transport. Curr. Pharm. Biotechnol. 13, 352-364.
32. Smith, J. D., Miyata, M., Ginsberg, M., Grigaux, C., Shmookler, E., et al. (1996) Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors. J. Biol. Chem. 271, 30647-30655. (Pubitemid 26404080)
33. Bortnick, A. E., Rothblat, G. H., Stoudt, G., Hoppe, K. L., Royer, L. J., et al. (2000) The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J. Biol. Chem. 275, 28634-28640.
34. Oram, J. F., Lawn, R. M., Garvin, M. R., and, Wade, D. P., (2000) ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem. 275, 34508-34511.
35. Kiss, R. S., Maric, J., and, Marcel, Y. L., (2005) Lipid efflux in human and mouse macrophagic cells: evidence for differential regulation of phospholipid and cholesterol efflux. J. Lipid Res. 46, 1877-1887. (Pubitemid 41248484)
36. Haidar, B., Denis, M., Krimbou, L., Marcil, M., and, Genest, J., Jr., (2002) cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts. J. Lipid Res. 43, 2087-2094. (Pubitemid 35471076)
37. See, R. H., Caday-Malcolm, R. A., Singaraja, R. R., Zhou, S., Silverston, A., et al. (2002) Protein kinase A site-specific phosphorylation regulates ATP-binding cassette A1 (ABCA1)-mediated phospholipid efflux. J. Biol. Chem. 277, 41835-41842. (Pubitemid 35257494)
38. Haidar, B., Denis, M., Marcil, M., Krimbou, L., and, Genest, J., Jr., (2004) Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter. J. Biol. Chem. 279, 9963-9969. (Pubitemid 38372598)
39. Tang, C., Vaughan, A. M., and Oram, J. F., (2004) Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol. J. Biol. Chem. 279, 7622-7628. (Pubitemid 38294642)
40. Gelissen, I. C., Cartland, S., Brown, A. J., Sandoval, C., Kim, M., et al. (2010) Expression and stability of two isoforms of ABCG1 in human vascular cells. Atherosclerosis 208, 75-82.
41. Gelissen, I. C., Sharpe, L. J., Sandoval, C., Rao, G., Kockx, M., et al. (2012) Protein kinase A modulates the activity of a major human isoform of ABCG1. J. Lipid Res. 53, 2133-2140.
42. Burns, V., Sharpe, L. J., Gelissen, I. C., and, Brown, A. J., (2013) Species variation in ABCG1 isoform expression: implications for the use of animal models in elucidating ABCG1 function. Atherosclerosis 226, 408-411.
43. Mackay, H. J., and, Twelves, C. J., (2007) Targeting the protein kinase C family: are we there yet? Nat. Rev. Cancer 7, 554-562. (Pubitemid 46985395)
44. Theret, N., Delbart, C., Aguie, G., Fruchart, J. C., Vassaux, G., et al. (1990) Cholesterol efflux from adipose cells is coupled to diacylglycerol production and protein kinase C activation. Biochem. Biophys. Res. Commun. 173, 1361-1368.
45. Mendez, A. J., Oram, J. F., and Bierman, E. L., (1991) Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J. Biol. Chem. 266, 10104-10111. (Pubitemid 21906774)
46. Li, Q., Tsujita, M., and, Yokoyama, S., (1997) Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages. Biochemistry 36, 12045-12052. (Pubitemid 27440942)
47. Yamauchi, Y., Hayashi, M., Abe-Dohmae, S., and, Yokoyama, S., (2003) Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly. J. Biol. Chem. 278, 47890-47897. (Pubitemid 37523237)
48. Wang, Y., and, Oram, J. F., (2005) Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway. J. Biol. Chem. 280, 35896-35903. (Pubitemid 41633857)
49. Wang, Y., and, Oram, J. F., (2007) Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C delta pathway. J. Lipid Res. 48, 1062-1068. (Pubitemid 46708673)
50. Zhou, X., Yin, Z., Guo, X., Hajjar, D. P., and, Han, J., (2010) Inhibition of ERK1/2 and activation of liver X receptor synergistically induce macrophage ABCA1 expression and cholesterol efflux. J. Biol. Chem. 285, 6316-6326.
51. Nofer, J. R., Feuerborn, R., Levkau, B., Sokoll, A., Seedorf, U., et al. (2003) Involvement of Cdc42 signaling in apoA-I-induced cholesterol efflux. J. Biol. Chem. 278, 53055-53062. (Pubitemid 38035908)
52. Zhao, G. J., Yin, K., Fu, Y. C., and, Tang, C. K., (2012) The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids. Mol. Med. 18, 149-158.
53. Martinez, L. O., Agerholm-Larsen, B., Wang, N., Chen, W., and, Tall, A. R., (2003) Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J. Biol. Chem. 278, 37368-37374. (Pubitemid 37175255)
54. Wang, N., Chen, W., Linsel-Nitschke, P., Martinez, L. O., Agerholm-Larsen, B., et al. (2003) A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J. Clin. Invest. 111, 99-107. (Pubitemid 36134853)
55. Roosbeek, S., Peelman, F., Verhee, A., Labeur, C., Caster, H., et al. (2004) Phosphorylation by protein kinase CK2 modulates the activity of the ATP binding cassette A1 transporter. J. Biol. Chem. 279, 37779-37788. (Pubitemid 39195492)
56. Le Goff, W., Peng, D. Q., Settle, M., Brubaker, G., Morton, R. E., et al. (2004) Cyclosporin A traps ABCA1 at the plasma membrane and inhibits ABCA1-mediated lipid efflux to apolipoprotein A-I. Arterioscler. Thromb. Vasc. Biol. 24, 2155-2161. (Pubitemid 39482445)
57. Schreiber, S. L., and, Crabtree, G. R., (1992) The mechanism of action of cyclosporin A and FK506. Immunol. Today 13, 136-142.
58. Karwatsky, J., Ma, L., Dong, F., and, Zha, X., (2010) Cholesterol efflux to apoA-I in ABCA1-expressing cells is regulated by Ca2+-dependent calcineurin signaling. J. Lipid Res. 51, 1144-1156.
59. Luu, W., Sharpe, L. J., and, Brown, A. J., Protein tyrosine phosphatase inhibition down-regulates ligand-induced ABCA1 expression. Atherosclerosis, in press.
60. Cohen P., (2010) Guidelines for the effective use of chemical inhibitors of protein function to understand their roles in cell regulation. Biochem. J. 425, 53-54.
61. Takahashi, Y., and, Smith, J. D., (1999) Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway. Proc. Natl. Acad. Sci. USA 96, 11358-11363. (Pubitemid 29487385)
62. Soltoff, S. P., (2007) Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta. Trends Pharmacol. Sci. 28, 453-458. (Pubitemid 47371266)